Complete AIDS pill being developed by two drug companies

home   >   blogdigger

Bristol-Myers Squibb And Gilead Sciences Establish US Joint Venture To Develop And Commercialize Fixed-Dose Combination Of Three HIV Medicines - First Collaboration to Develop a Once-Daily Antiretroviral Fixed-Dose RegimenBristol-Myers Squibb Company (NYSE: BMY) and Gilead Sciences, Inc (Nasdaq: GILD) today announced details of a joint venture to develop and commercialize the fixed-dose combination of Bristol-Myers Squibb's SustivaŽ (efavirenz) and Gilead's Truvada? (emtricitabine and tenofovir ... (more)  

- link to Complete AIDS pill being developed by two drug companies -
Last update: 05/26/2005

Recommended Reading

    From a twinkle in the eye to a blockbuster drug: the story of Celebrex[R] holds lessons for R&D leaders everywhere. (The IRI Medalist's Address).(Brie ... article from: Research-Technology Management
    Prozac and the New Antidepressants: What You Need to Know About Prozac, Zoloft, Paxil, Luvox, Wellbutrin, Effexor, Serzone, and More
    Uncertain about COX-2s? NSAID + PPI is alternative.(News) : An article from: Family Practice News
    Actos fallidos. (anlisis del boxeo)(TT: Failed attempts) (TA: analysis of boxing) : An article from: Proceso
    Zocor - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
    Gestion de Los Recursos Humanos y del Medio Ambien
    Quetiapine promising for developmental disorders. (Children and Teens). : An article from: Clinical Psychiatry News
    States Respond to Growing Abuse of Painkiller. : An article from: State Legislatures